DelveInsight's Macrophage Activation Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, macrophage activation syndrome emerging drugs, market share ...
When a drug is injected directly into a tumour, macrophages already present in the body absorb the drug and begin producing ...
Researchers identify altered expression of genes that worsens periodontitis among smokers, and a new target molecule ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
The market was valued at $110m in 2024. The macrophage activation syndrome sector in the six major markets (6MM) is expected ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
Piezoelectric nanoparticles deployed inside immune cells and stimulated remotely by ultrasound can trigger the body's disease ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...